Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis ; volume:9 ; number:1 ; day:1 ; month:3 ; year:2019 ; pages:1-15 ; date:12.2019
Scientific reports ; 9, Heft 1 (1.3.2019), 1-15, 12.2019
- Classification
-
Naturwissenschaften
- Creator
-
Schau, Isabell
Michen, Susanne
Hagstotz, Alexander
Janke, Andreas
Schackert, Gabriele
Appelhans, Dietmar
Temme, Achim
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-019-40032-8
- URN
-
urn:nbn:de:101:1-2019032321261869549052
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Schau, Isabell
- Michen, Susanne
- Hagstotz, Alexander
- Janke, Andreas
- Schackert, Gabriele
- Appelhans, Dietmar
- Temme, Achim
- SpringerLink (Online service)
Other Objects (12)
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
In vitro assessment of antibody-conjugated gold nanorods for systemic injections
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone
In vitro assessment of antibody-conjugated gold nanorods for systemic injections
Differential toll-like receptor 3 (TLR3) expression and apoptotic response to TLR3 agonist in human neuroblastoma cells
Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Enhanced Efficacy of a TLR3 Agonist Delivered by Cowpea Chlorotic Mottle Virus Nanoparticles
Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia
Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics
Anti-Fn14 antibody-conjugated nanoparticles display membrane TWEAK-like agonism
Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus‐specific neutralizing antibody response
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell responses in mice
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone